DJE Kapital AG

Position in JNJ — Johnson & Johnson

CIK 1659196 82049 PULLACH, 2M

Position in JNJ

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$129,697,907

-$53,985,064 QoQ

Shares Held

510,682

-32.0% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

2.48%

of 13F equity value

Holder Rank

#263

of 4,664 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 50% Shared 0% None 50%

Healthcare · as of Jun 30, 2026

DJE Kapital AG holds $622,435,226 across 5 Drug Manufacturers - General names. JNJ ranks #3 (20.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	246,220	$295,323,679
2	MRK	Merck & Co., Inc.	1,431,324	$183,925,134
3	JNJ	Johnson & Johnson This page	510,682	$129,697,907
4	AZN	Astrazeneca PLC	62,650	$11,879,693
5	GILD	Gilead Sciences, Inc.	12,734	$1,608,813

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$129,697,907	510,682	-32.0%	Shares	Sole	2026-08-04
2026-03-31	$183,682,971	751,444	-9.1%	Shares	Sole	2026-05-08
2025-12-31	$171,019,134	826,379	+3633.5%	Shares	Sole	2026-02-12
2025-09-30	$4,104,086	22,134	0.0%	Shares	Sole	2025-10-30
2025-06-30	$3,380,968	22,134	+14.3%	Shares	Sole	2025-08-07
2025-03-31	$3,211,325	19,364	0.0%	Shares	Sole	2025-05-09
2024-12-31	$2,800,421	19,364	—	Shares	Sole	2025-02-06
No filing history on record for this holder in this stock.